Clinical Trial Update: Association of PICP Serum Marker in Patients With LVSD

View source ↗

Summary

The clinical trial examining the association of the PICP serum marker in patients with left ventricular systolic dysfunction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Left Ventricular Systolic Dysfunction

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Systolic Dysfunction | Status: TERMINATED